Literature DB >> 7558135

Induction of diabetes with islet-specific T-cell clones is age dependent.

J D Peterson1, B Pike, A Dallas-Pedretti, K Haskins.   

Abstract

To investigate the effects of recipient age on the induction of diabetes by CD4+ islet-specific T-cell clones, we tested four different clones in non-obese diabetic (NOD) mice of different ages. Transfer of each of the T-cell clones resulted in insulitis and full development of diabetes in unirradiated 8-18-day-old NOD mice within 2-3 weeks. A small gender bias in disease susceptibility was seen in 8-14-day-old female NOD mice, which showed a twofold increase in disease incidence over both age-matched males and slightly older (15-18-day-old) females. In contrast, both male and female NOD mice, 19 days or older, were highly resistant to T-cell clone-induced insulitis and completely resistant to the development of diabetes. In mice of an intermediate age range (15-18 days old), two of the clones showed a three- to fourfold reduction in transfer of overt diabetes regardless of gender. These results suggest that an important developmental event occurs in both male and female NOD mice between the age of 15 and 19 days, leading to the inhibition of disease induced by T-cell clones.

Entities:  

Mesh:

Year:  1995        PMID: 7558135      PMCID: PMC1383920     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  T-lymphocyte clone specific for pancreatic islet antigen.

Authors:  K Haskins; M Portas; B Bradley; D Wegmann; K Lafferty
Journal:  Diabetes       Date:  1988-10       Impact factor: 9.461

2.  Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors.

Authors:  S Candéias; J Katz; C Benoist; D Mathis; K Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone.

Authors:  K Haskins; M McDuffie
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

4.  An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.

Authors:  E P Reich; R S Sherwin; O Kanagawa; C A Janeway
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

5.  Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.

Authors:  S W Christianson; L D Shultz; E H Leiter
Journal:  Diabetes       Date:  1993-01       Impact factor: 9.461

6.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

Authors:  B J Miller; M C Appel; J J O'Neil; L S Wicker
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

7.  Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen.

Authors:  B Bergman; K Haskins
Journal:  Diabetes       Date:  1994-02       Impact factor: 9.461

8.  The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males.

Authors:  P R Hutchings; A Cooke
Journal:  J Autoimmun       Date:  1990-04       Impact factor: 7.094

9.  Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.

Authors:  J D Peterson; B Pike; M McDuffie; K Haskins
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

10.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.

Authors:  C Boitard; R Yasunami; M Dardenne; J F Bach
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  3 in total

1.  Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

Authors:  David H Wagner; Gisela Vaitaitis; Richard Sanderson; Michelle Poulin; Cathleen Dobbs; Kathryn Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 2.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

3.  Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

Authors:  Sylvaine You; Lynn Poulton; Steve Cobbold; Chih-Pin Liu; Michael Rosenzweig; Douglas Ringler; Wen-Hui Lee; Berta Segovia; Jean-François Bach; Herman Waldmann; Lucienne Chatenoud
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.